Metabolic Reprogramming in Cancer Cell Dynamics

Cancer cells rewire their metabolism to support rapid proliferation, survival under stress and metastatic spread. This reprogramming encompasses a shift from mitochondrial oxidative phosphorylation to aerobic glycolysis, enhanced uptake of nutrients such as glucose and glutamine, and engagement of ancillary pathways including the pentose phosphate pathway and lipid synthesis. Metabolic flexibility allows tumour cells to adapt to fluctuating oxygen and nutrient levels within the microenvironment, to resist therapy and to fuel biosynthetic demands. Interactions between metabolic pathways and canonical oncogenic signals—such as PI3K/AKT/mTOR, Myc and hypoxia-inducible factors—establish feedback loops that reinforce malignant phenotypes. Spatial and temporal heterogeneity of metabolic states within tumours underlies differential responses to treatment and influences immune cell function. Understanding these dynamic adaptations has illuminated new vulnerabilities, from enzyme inhibitors to dietary interventions, offering avenues for precision therapies that target cancer’s metabolic underpinnings.

Research from Nature Portfolio

Recent studies have mapped the structural organisation of mitochondrial networks in non-small cell lung carcinoma, revealing that high oxidative phosphorylation tumours form peri-droplet mitochondrial assemblies around lipid stores, whereas low-oxidative phenotypes localise mitochondria perinuclearly and remodel cristae to boost glycolytic flux. This compartmentalisation dictates bioenergetic capacity and therapeutic sensitivity. Complementary single-cell analyses across melanoma and head-and-neck cancers have uncovered profound intratumour metabolic heterogeneity, demonstrating that malignant cells exhibit higher mitochondrial and glycolytic activity than bulk assays suggest, with both programmes tightly correlated with local hypoxia. These findings establish a high-resolution framework for linking subcellular mitochondrial architecture and single-cell metabolic states to tumour progression and treatment response.

Metabolic Reprogramming in Cancer Cell Dynamics publication trend

The graph below shows the total number of articles in metabolic reprogramming in cancer cell dynamics across all publications each year (not limited to Nature Index journals).

Technical terms

Aerobic glycolysis: Conversion of glucose to lactate in the presence of oxygen, providing ATP and biosynthetic intermediates for proliferating cells.
Oxidative phosphorylation (OXPHOS): Mitochondrial process coupling electron transport to ATP synthesis via oxygen consumption.
Tricarboxylic acid (TCA) cycle: Mitochondrial pathway oxidising acetyl-CoA to generate reducing equivalents and anabolic precursors.
Anaplerosis: Refilling of TCA cycle intermediates through pathways such as glutamine conversion to α-ketoglutarate, supporting biosynthesis.

References

1. Spatial mapping of mitochondrial networks and bioenergetics in lung cancer. Nature (2023).
2. Metabolic landscape of the tumor microenvironment at single cell resolution. Nature Communications (2019).
3. Tumor glycolysis as a target for cancer therapy: progress and prospects. Molecular Cancer (2013).
4. Emerging roles of lipid metabolism in cancer metastasis. Molecular Cancer (2017).
5. Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets. Cells (2020).